logo
Audience Analytics eyes growth in Vietnam, M&A opportunities

Audience Analytics eyes growth in Vietnam, M&A opportunities

Business Times25-05-2025

[SINGAPORE] Audience Analytics, an organiser of regional business awards and career fairs, is seeking growth in Vietnam with its recent investment in a business partner there, while looking out for merger and acquisition (M&A) opportunities.
On May 15, the company inked a deal to acquire 30 per cent of Snowball, a Vietnam-based management consultancy, for 17.5 billion dong (S$870,000).
Snowball has partnered Audience Analytics to organise business awards since 2018, said the Catalist-listed company's chairman and managing director William Ng.
'It's a natural progression of what has already been a great partnership… We see a lot of potential to grow further in Vietnam,' he said, adding that he shares knowledge and resources with Snowball, while retaining its 'entrepreneurial spirit'.
Snowball is next set to organise a new career fair in June – called the Vietnam Career and Training Fair – as a licensee of Audience Analytics.
The event is modelled after Audience Analytics' signature event, the Malaysia Career and Training Fair, which the company has organised since its founding in 2002.
BT in your inbox
Start and end each day with the latest news stories and analyses delivered straight to your inbox.
Sign Up
Sign Up
Audience Analytics' expansion in Vietnam is in line with its broader pursuit of growth in what Ng dubs the 'CLMV market', comprising Cambodia, Laos, Myanmar and Vietnam.
'These markets are all very young. We see a fast-growing workforce and a lot of opportunities to expand (our) reach there via our existing partnership in Vietnam,' said Ng.
Audience Analytics is also on the lookout for M&A opportunities. The company is sitting on S$21.6 million in cash as at Dec 31, 2024, with S$2.8 million in current liabilities.
'It makes a lot of sense for us to convert some of this cash holding into more revenue and more profit via the M&A route. We are currently in active discussion with a number of potential partners,' he said.
Proxy to business sentiment
Audience Analytics' growth plans come amid challenging economic conditions, with the US' tariff war dampening the growth outlook for South-east Asia.
The company's main revenue driver is its business awards segment, through which it earns participation fees. Its key awards include SME100, HR Asia Best Companies to Work for in Asia, CXP Best Customer Experience Awards, and the Golden Bull Award.
These awards are held in 15 markets across the region, spanning South-east Asia, India, China and South Korea.
Besides exhibitions and awards, Audience Analytics is also a publisher of business-to-business digital and print media.
The company is a 'proxy' to overall business sentiment, noted Ng. 'If businesses do well and they're happy about it, the likelihood of them investing in our products – whether it's the exhibitions, media or business analytics – will be higher,' he said.
He acknowledged that sentiment has been uncertain this year, but with the recent tariff truce between US and China, Ng is more sanguine about the outlook. 'We no longer see the reciprocal tariffs to be a major impediment to our revenue this year.'
He also sees Audience Analytics' geographical breadth as a 'major hedge' against volatility. Ng pointed to how the company fared well in FY2024 despite a 'very difficult' year, thanks to continued growth and cost discipline.
Audience Analytics posted a 28.8 per cent rise in net profit to S$6 million for the year ended Dec 31, 2024. This was on the back of a 6.5 per cent rise in revenue to S$15.6 million. The top-line expansion was driven by the awards segment, where revenue rose 7.7 per cent to S$14.5 million.
'What I found was our real achievement in 2024 was that we managed to reign in the incremental cost, and we delivered a very strong bottom line,' said Ng.
That said, performance was weaker in other segments. Revenue from the exhibitions business was down 6.6 per cent to S$1 million, due to softer demand. The business media and analytics segment's sales fell even more steeply – by 31 per cent – to S$46,165.
Acknowledging that media is a tough business, Ng said that this vertical is 'not just about the money', but also about brand-building.
He cited how the 18-year-old SME Magazine in Malaysia 'is almost a household name'. The company's SME-related awards and events gain more recognition when people associate it with the magazine, Ng said.
Plenty of runway
Despite the market volatility in the past few years, Audience Analytics' share price has risen 31.1 per cent since its 2021 listing. It is also up 10.8 per cent since the start of the year to S$0.295 as at May 23.
Ng is not too concerned about the share price, but hopes to attract investors with a long-term view and reward them.
One sweetener is the company's new dividend policy – it aims to pay out at least 50 per cent of profits as dividends for FY2025 to FY2027.
He is also 'constantly on the lookout for new strategies' to improve liquidity for investors. The company recently issued investors one bonus share for every three ordinary shares, which has made 'the stock a lot more liquid now than a year ago', noted Ng.
Asked how investors should view Audience Analytics, he said: 'This is a young company with plenty of runway, and a company that truly values investors.'

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Japan curry shops see record bankruptcies as rice prices soar
Japan curry shops see record bankruptcies as rice prices soar

Business Times

time33 minutes ago

  • Business Times

Japan curry shops see record bankruptcies as rice prices soar

[TOKYO] A record number of curry shops in Japan went out of business in the past year, as purveyors of one of the country's most beloved dishes took a hit from soaring rice prices. Thirteen curry shops with more than 10 million yen (S$89,345) in debt filed for bankruptcy in the year ending in March – marking a record high for the second consecutive year, according to a report from Tokyo-based research firm Teikoku Databank. The total number of bankruptcies is likely much higher when considering smaller mom-and-pop shops, Teikoku said. Prices of mainstay ingredients in Japanese curry – such as rice, spices, meat and vegetables – have gone up due to a rice shortage, adverse weather and a weak yen, the report said. Higher energy prices have also dented the profits of shop operators. Japanese curry, a thick brown sauce containing meat and vegetables, is usually served on a bed of rice. A basic curry rice dish, a classic comfort food, now costs 365 yen – a record high, according to Teikoku. Prime Minister Shigeru Ishiba's government has been scrambling to combat skyrocketing rice prices in Japan by releasing stockpiles of the staple ahead of a summer election. During the coronavirus pandemic, takeout and delivery orders had fuelled a curry boom – that has now also slowed and hurt sales for curry shops, Teikoku said. BLOOMBERG

Cordlife collection rates still under pre-incident levels, but resumed Singapore operations are ‘encouraging'
Cordlife collection rates still under pre-incident levels, but resumed Singapore operations are ‘encouraging'

Business Times

time3 hours ago

  • Business Times

Cordlife collection rates still under pre-incident levels, but resumed Singapore operations are ‘encouraging'

[SINGAPORE] Cordlife said that the full resumption of its Singapore operations is an 'encouraging step' in restoring client confidence and regaining operational momentum, even though collection rates have not recovered to average levels from before a storage lapse in December 2023. The cord blood bank resumed operations earlier this year after the Ministry of Health (MOH) renewed its licences for cord blood banking and human tissue banking services with effect from Jan 14. The ministry had suspended it from carrying out operations after uncovering lapses in the storage of its cord-blood tanks. In a Friday (Jun 6) business update, the embattled private cord blood bank said that it is continuing to engage customers affected by the incident. As at May 30, 2025, 56 per cent of affected customers have accepted Cordlife's offers to refund annual fees they paid from the start of the temperature lapse, as well as its offers to waive all subsequent fees for active customers whose children's cord blood units (CBU) are stored in the damaged, high-risk tanks, and to continue storing the CBU of affected customer's children until their child turns 21. It added that it has received correspondence from clients, assessing the losses resulting from alleged breaches of contract, negligence and misrepresentation, and that it is 'actively monitoring' these matters in consultation with legal advisers and taking steps at appropriate junctures. To return to pre-incident levels of performance, Cordlife said, it will continue to expand its outreach initiatives in order to maintain a strong sales pipeline. BT in your inbox Start and end each day with the latest news stories and analyses delivered straight to your inbox. Sign Up Sign Up It sank into the red with a S$6.3 million net loss for its second half ended Dec 31, 2024, reversing from a S$1.3 million net profit in the previous corresponding period, as a result of the fallout from the lapses. Loss per share for the half-year stood at S$0.0247, from earnings per share of S$0.0051 previously. Its revenue plunged 32 per cent to S$18.7 million, from S$27.4 million, due to the suspension of its Singapore operations until Sep 14, 2024, after the lapses were discovered. In May this year, the group received a voluntary conditional cash partial offer from Medeze Treasury, a wholly owned subsidiary of Thai-listed stem cell company Medeze Group. The offer was for a 10 per cent stake in the group as Medeze is seeking to explore business opportunities with Cordlife. The group added that it has been taking 'active steps' to raise public awareness on the importance of cord blood banking and its role in safeguarding future health outcomes by ramping up marketing efforts. These measures include participating in baby fairs and engaging with the medical community to strengthen its ecosystem of doctors and hospitals. The group said it has strengthened and renewed relationships with the medical community in Singapore by engaging stakeholders in the community to inform them of its rectification efforts and improved procedures. It added that it is working closely with the Association for the Advancement of Blood and Biotherapies and the Foundation for the Accreditation of Cellular Therapy to restore its accreditations for Singapore. Shares of Cordlife ended Thursday 1.9 per cent or S$0.005 higher at S$0.275, before the announcement.

Cordlife collection rates have not recovered to pre-incident levels, but resumption of Singapore operations are ‘encouraging'
Cordlife collection rates have not recovered to pre-incident levels, but resumption of Singapore operations are ‘encouraging'

Business Times

time3 hours ago

  • Business Times

Cordlife collection rates have not recovered to pre-incident levels, but resumption of Singapore operations are ‘encouraging'

[SINGAPORE] Cordlife said that the full resumption of its Singapore operations is an 'encouraging step' in restoring client confidence and regaining operational momentum, even though collection rates remain below average levels from before a storage lapse in December 2023. The cord blood bank resumed operations earlier this year after the Ministry of Health (MOH) renewed its licences for cord blood banking and human tissue banking services with effect from Jan 14. The ministry had suspended it from carrying out operations after uncovering lapses in the storage of its cord-blood tanks. In a Friday (Jun 6) business update, the embattled private cord blood bank said that it is continuing to engage customers affected by the incident. As at May 30, 2025, 56 per cent of affected customers have accepted Cordlife's offers to refund annual fees they paid from the start of the temperature lapse, as well as its offers to waive all subsequent fees for active customers whose children's cord blood units (CBU) are stored in the damaged, high-risk tanks, and to continue storing the CBU of affected customer's children until their child turns 21. It added that it has received correspondence from clients, assessing the losses resulting from alleged breaches of contract, negligence and misrepresentation, and that it is 'actively monitoring' these matters in consultation with legal advisers and taking steps at appropriate junctures. To return to pre-incident levels of performance, Cordlife said, it will continue to expand its outreach initiatives in order to maintain a strong sales pipeline. BT in your inbox Start and end each day with the latest news stories and analyses delivered straight to your inbox. Sign Up Sign Up It sank into the red with a S$6.3 million net loss for its second half ended Dec 31, 2024, reversing from a S$1.3 million net profit in the previous corresponding period, as a result of the fallout from the lapses. Loss per share for the half-year stood at S$0.0247, from earnings per share of S$0.0051 previously. Its revenue plunged 32 per cent to S$18.7 million, from S$27.4 million, due to the suspension of its Singapore operations until Sep 14, 2024, after the lapses were discovered. In May this year, the group received a voluntary conditional cash partial offer from Medeze Treasury, a wholly owned subsidiary of Thai-listed stem cell company Medeze Group. The offer was for a 10 per cent stake in the group as Medeze is seeking to explore business opportunities with Cordlife. The group added that it has been taking 'active steps' to raise public awareness on the importance of cord blood banking and its role in safeguarding future health outcomes by ramping up marketing efforts. These measures include participating in baby fairs and engaging with the medical community to strengthen its ecosystem of doctors and hospitals. The group said it has strengthened and renewed relationships with the medical community in Singapore by engaging stakeholders in the community to inform them of its rectification efforts and improved procedures. It added that it is working closely with the Association for the Advancement of Blood and Biotherapies and the Foundation for the Accreditation of Cellular Therapy to restore its accreditations for Singapore. Shares of Cordlife ended Thursday 1.9 per cent or S$0.005 higher at S$0.275, before the announcement.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store